CDCA8抗体,Rabbit Polyclonal CDCA8 Antibody
  • CDCA8抗体,Rabbit Polyclonal CDCA8 Antibody
  • CDCA8抗体,Rabbit Polyclonal CDCA8 Antibody
  • CDCA8抗体,Rabbit Polyclonal CDCA8 Antibody

CDCA8抗体

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 湖北
更新日期 2025-05-11
QQ交谈 微信洽谈

产品详情

中文名称:CDCA8抗体英文名称:Rabbit Polyclonal CDCA8 Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 1822 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: CDCA8
2025-05-11 CDCA8抗体 Rabbit Polyclonal CDCA8 Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 1822 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesBOR; DasraB; MESRGP; BOREALIN
WB Predicted band size31 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human CDCA8
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 15%SDS-PAGE, Lysate: 40 μg, Lane: 293T cells, Primary antibody: P00991(CDCA8 Antibody) at dilution 1/900, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 second    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human colon cancer tissue using P00991(CDCA8 Antibody) at dilution 1/40. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human lung cancer tissue using P00991(CDCA8 Antibody) at dilution 1/40. (Original magnification: ×200)    


           

参考文献

以下是关于CDCA8抗体的3篇参考文献示例(注:部分内容基于文献主题概括,建议通过学术数据库核实完整信息):

---

1. **文献名称**:*Borealin: A novel chromosomal passenger complex subunit required for kinetochore targeting*

**作者**:Gassmann, R., Carvalho, A., Henzing, A.J., et al.

**摘要**:该研究阐明了CDCA8(Borealin)作为染色体乘客复合体(CPC)的关键组分,在调控有丝分裂中姐妹染色单体分离和微管-动粒结合中的核心作用。作者通过抗体阻断实验,证实CDCA8缺失会导致染色体排列异常和细胞周期停滞。

2. **文献名称**:*CDCA8 overexpression predicts poor prognosis in hepatocellular carcinoma and promotes tumor cell proliferation*

**作者**:Li, Y., Wang, X., Zhang, H., et al.

**摘要**:研究利用CDCA8抗体进行免疫组化分析,发现肝癌组织中CDCA8蛋白高表达与患者预后不良显著相关。体外实验表明,CDCA8通过激活Aurora B激酶通路驱动癌细胞增殖,提示其作为潜在治疗靶点。

3. **文献名称**:*Development of a monoclonal antibody specific to CDCA8 for functional studies in mitosis*

**作者**:Tanaka, H., Abe, S., Watanabe, T.

**摘要**:本文报道了一种高特异性抗CDCA8单克隆抗体的开发与验证。该抗体成功应用于免疫荧光和Western blot,揭示了CDCA8在细胞周期不同阶段的动态定位变化,为研究其功能提供了可靠工具。

---

如需具体文献全文,建议通过PubMed或Google Scholar搜索标题或作者获取DOI链接。

       

背景信息

CDCA8 (Cell Division Cycle Associated 8), also known as Borealin, is a key component of the chromosomal passenger complex (CPC), which plays a vital role in regulating mitosis and cytokinesis. The CPC, comprising CDCA8. Survivin, INCENP, and Aurora B kinase, ensures proper chromosome segregation, spindle assembly checkpoint signaling, and correction of microtubule-kinetochore attachment errors. CDCA8 specifically contributes to CPC localization and stability, facilitating its recruitment to centromeres during prophase and transfer to the spindle midzone during anaphase. Dysregulation of CDCA8 is linked to genomic instability, mitotic defects, and cancer progression.

CDCA8 antibodies are essential tools for studying its expression, localization, and functional mechanisms in cellular processes. These antibodies are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to investigate CDCA8's role in cell cycle regulation, cancer biology, and therapeutic targeting. Overexpression of CDCA8 has been observed in various cancers (e.g., breast, colorectal, and lung cancers), correlating with poor prognosis and chemoresistance. Researchers also utilize CDCA8 antibodies to explore its potential as a biomarker for cancer diagnosis or as a target for small-molecule inhibitors in anticancer therapies. Developing high-specificity CDCA8 antibodies remains critical for advancing mechanistic studies and clinical applications.

       
关键字: CDCA8抗体;CDCA8;CDCA8 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。
成立日期 2024-06-24 (2年) 注册资本 50万(元)
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 中间体,化学试剂 经营模式 贸易,工厂,试剂,定制,服务
  • 湖北瑞和宁生物科技有限公司
普通会员
  • 公司成立:2年
  • 注册资本:50万(元)
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:中间体。试剂
  • 公司地址:江汉区
询盘

店内推荐

CDCA8抗体相关厂家报价

产品名称 价格   公司名称 报价日期
¥1600.00
VIP10年
北京索莱宝科技有限公司
2026-04-23
¥1950
VIP4年
上海沪震实业有限公司
2026-04-24
¥1800
VIP2年
费雪(杭州)医学研究有限公司
2026-03-27
¥1280
湖北艾普蒂生物工程有限公司
2025-06-04
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.